團(tuán)隊人員

1.   研究組長：池在龍研究員，醫(yī)學(xué)博士，研究生導(dǎo)師。浙江省高校“錢江學(xué)者”特聘教授， 溫州市“580海外精英引進(jìn)計劃”特聘專家，浙江省新世紀(jì)151人才工程第一層次培養(yǎng)人才。日本國立富山大學(xué)眼科學(xué)博士，日本學(xué)術(shù)振興會外國人特別研究員，日本國立東京醫(yī)療中心研究員，美國哈佛醫(yī)學(xué)院博士后。十二年的海外學(xué)習(xí)和工作后，于2014年回到溫州醫(yī)科大學(xué)組建實驗室。參與眼科精準(zhǔn)醫(yī)療學(xué)科創(chuàng)新引智基地“111”計劃。

2.   工作人員：戴小丹、李童、劉西媛

研究方向

  1. 神經(jīng)退行性眼病發(fā)病機(jī)制及其治療新方法的開發(fā)

  2. 新生血管性眼病的發(fā)病機(jī)制研究及其干預(yù)治療方法的開發(fā)

  3. 葡萄膜炎發(fā)病機(jī)制研究及其診斷技術(shù)和藥物開發(fā)

Laboratory of Neurovascular Biology

Team members

1.       Principle Investigator: Zai-Long Chi, MD, PhD

Zai-Long Chi received his PhD degree in the Department of Ophthalmology at University of Toyama, Japan and immediately joined the National Hospital Organization Tokyo Medical Center as JSPS Fellow and investigator. Then, he joined at Harvard Medical School as research fellow. After 12 years overseas study and work, he returned to China in 2014 and established his own lab at Wenzhou Medical University. His research focuses on the major blindness eye diseases, such as glaucoma, age-related macular degeneration and uveitis to understand the mechanism of the disease onset. He is winner of “Qianjiang scholar” professorship and “580 Plan”, the first level of “151 talents project” in Zhejiang province. He participated in the State Bureau of higher school subject innovation engineering plan -“Precision Medicine of Ophthalmology”.

2.       Team Staff: XiaoDan Dai, Tong Li and XiYuan Liu

Scope of Research Proposal

1.       The pathogenesis of neurodegenerative diseases, discovery and development of the novel therapy

 2.     The pathogenesis of neovascular eye disease and the development of intervention therapy

      3.     The pathogenesis of uveitis and its diagnosis and therapy